Mr. Traynor previously spent 10 years at Genzyme Corporation, most recently serving as senior vice president of business unit finance. At ConforMIS he will be responsible for SEC filings, controllership functions and financial planning and forecasting for Genzyme’s eight global business units.
More Articles on Orthopedic Device Companies:
15 Device Company Financial Reports
Tornier 3Q Sales Flat at $58M
DePuy Launches New Trumatch Pin for Orthopedic Implants
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
